Once daily evening dosing of mometasone furoate dry powder inhaler 200 μg is effective in patients with moderate persistent asthma

被引：0
|
作者：
Ramsdell, J. W. [1 ]
Bensch, G. W. [2 ]
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] Allergy Immunol & Asthma Grp, Stockton, CA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2008年 / 121卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2007.12.574
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
601
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [41] High-dose mometasone furoate dry powder inhaler is effective and safe in a refractory corticosteroid-dependent asthma patient
    Nsouli, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A23 - A23
  • [42] The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing
    Kempsford, Rodger D.
    Oliver, Amanda
    Bal, Joanne
    Tombs, Lee
    Quinn, Dean
    RESPIRATORY MEDICINE, 2013, 107 (12) : 1873 - 1880
  • [43] Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma
    Schmier, J
    Leidy, NK
    Gower, R
    JOURNAL OF ASTHMA, 2003, 40 (04) : 383 - 393
  • [44] Once-daily Symbicort (budesonide/eformoterol in a single inhaler) is effective in moderate-persistent asthma
    Buhl, R
    Creemers, JPHM
    Vondra, V
    Martelli, NA
    THORAX, 2001, 56 : 62 - 63
  • [45] Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
    Ashley Woodcock
    Eugene R Bleecker
    William W Busse
    Jan Lötvall
    Neil G Snowise
    Lucy Frith
    Loretta Jacques
    Brett Haumann
    Eric D Bateman
    Respiratory Research, 12
  • [46] Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
    Woodcock, Ashley
    Bleecker, Eugene R.
    Busse, William W.
    Lotvall, Jan
    Snowise, Neil G.
    Frith, Lucy
    Jacques, Loretta
    Haumann, Brett
    Bateman, Eric D.
    RESPIRATORY RESEARCH, 2011, 12
  • [47] Reduction of Nocturnal Awakenings With Mometasone Furoate Administered Via Dry Powder Inhaler in Children With Persistent Asthma Previously Receiving Other Inhaled Corticosteroids
    Berger, W. E.
    Noonan, M.
    Teper, A.
    Moreno-Cantu, J.
    Stryszak, P.
    Meltzer, E. O.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB159 - AB159
  • [48] COST-EFFECTIVENESS OF ONCE-DAILY SINGLE-INHALER INDACATEROL ACETATE/GLYCOPYRRONIUM BROMIDE/MOMETASONE FUROATE IN PATIENTS WITH UNCONTROLLED MODERATE-TO-SEVERE ASTHMA
    Gupta, S.
    Muthukumar, M.
    Marvel, J.
    Kaur, H.
    Ishikawa, R.
    Hasani, I
    Mtibaa, M.
    Olivenstein, R.
    VALUE IN HEALTH, 2020, 23 : S723 - S724
  • [49] Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma
    Michael Noonan
    Jeffrey Leflein
    Jonathan Corren
    Heribert Staudinger
    BMC Pediatrics, 9
  • [50] Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma
    Noonan, Michael
    Leflein, Jeffrey
    Corren, Jonathan
    Staudinger, Heribert
    BMC PEDIATRICS, 2009, 9
12345